Adjuvant TACE in HCC With High-risk Recurrence Factors
Abroad (travel likely)RecruitingPHASE3
Conditions
Hepatocellular Carcinoma · Adjuvant · Transarterial Chemoembolization
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Guangxi Medical University Cancer Hospital, Nanning, China
Contact: Principal Investigator (Jian-Hong Zhong, PhD)
Study leads
Jian-Hong Zhong
Principal Investigator
Guangxi Medical University Cancer Hospital